Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Former Allergan exec Douglas Ingram named Chase Pharma CEO

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Williams setting up shop at Codiak after Biogen departure

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Regeneron expanding New York campus again, adding 300 jobs

Rapidly expanding Eylea-maker Regeneron Thursday announced that it will invest another $150 million to grow its Tarrytown, NY, campus with plans to add another 300 jobs,  The Journal News  reports.

Quintiles names Jack Greenberg its next chairman

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Pfizer, Allergan eyeing Saunders for CEO spot if a deal goes through: Bloomberg

Pfizer and Allergan are currently in "friendly" merger talks. And if they do tie the knot, it's looking like Allergan CEO Brent Saunders will take the helm.

Aveo's Ha-Ngoc steps down after years of clinical failure

Former Aveo Oncology CEO Tuan Ha-Ngoc has left his post as chairman of the company's board, walking away from the struggling drugmaker as it tries to reverse a long line of missteps.

Valeant board, Ackman back CEO Pearson as shares continue downward dive

Valeant's stock price may have hit its lowest point in more than two years, but the company's board and enthusiast investor Bill Ackman still say CEO J. Michael Pearson is the one for the job.

Insys CEO Michael Babich steps down

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Former Covidien CEO Almeida to head Baxter

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

China's ZAI Lab goes novel in drug development, makes key hire

Shanghai-based biotech ZAI Lab said it has partnered with the Tsinghua University Immunology Institute on R&D to discover and develop new drugs and also noted the hire of a senior drug development executive, putting it on a path to novel development from a predominantly in-licensing model since launching in 2013.
'